Columbia Research Enhanced Value ETF
REVS
1 hedge funds and large institutions have $4.97M invested in Columbia Research Enhanced Value ETF in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
99.88% more ownership
Funds ownership: 0% → 99.88% (+100%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$4.97M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Wells Fargo
San Francisco,
California
| $4.97M | +$4.97M | +249,700 | New |
|
REVS Hedge Fund Activity: Q3 2019 in Review
1 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q3 2019, worth a combined $4.97M.
Buyers outnumbered sellers: 1 fund opened new REVS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Wells Fargo, opening a new position worth an estimated $4.97M.
- 1 institutional investor held Columbia Research Enhanced Value ETF (REVS) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $4.97M of Columbia Research Enhanced Value ETF stock for Q3 2019.
- 1 fund opened new Columbia Research Enhanced Value ETF positions in Q3 2019 and 0 closed out, a net change of +1 holder.
- The largest Columbia Research Enhanced Value ETF buyer in Q3 2019 was Wells Fargo, an estimated $4.97M added.
Based on aggregated 13F filings for Q3 2019.